chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 28.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Chills, Feeling abnormal, Headache, Lip swelling
Clinical narrative: This case was received from a local health authority on 03 November 2008, under VAERS reference number 328067. A 28-year-old female, with no reported medical history, received an injection of FLUZONE SV 2008-2009 (lot number U2806AA) on 08 October 2008. Within 30 minutes of vaccination, she experienced a headache, and began "feeling poor" two hours later. Over the next four hours, she complained of red eyes, lip swelling, fever, chills, tremors, chest pressure, sore throat, and a pounding heart (the reporter described being able to "feel it beating in her legs"). Six hours post-vaccination, she took MOTRIN and went to bed. She felt better the following morning, and the event was considered to be resolved. Follow-up information was extracted from the VAERS database via a search of QScan on 24 February 2009. The FLUZONE was injected intramuscularly, and all events occurred on 08 October 2008. VAERS reference number was provided as 328067.
Age: 28.0
Sex: F
Vaccine: FLU3
Symptoms: Ocular hyperaemia, Oropharyngeal pain, Palpitations, Pyrexia, Tremor
Clinical narrative: This case was received from a local health authority on 03 November 2008, under VAERS reference number 328067. A 28-year-old female, with no reported medical history, received an injection of FLUZONE SV 2008-2009 (lot number U2806AA) on 08 October 2008. Within 30 minutes of vaccination, she experienced a headache, and began "feeling poor" two hours later. Over the next four hours, she complained of red eyes, lip swelling, fever, chills, tremors, chest pressure, sore throat, and a pounding heart (the reporter described being able to "feel it beating in her legs"). Six hours post-vaccination, she took MOTRIN and went to bed. She felt better the following morning, and the event was considered to be resolved. Follow-up information was extracted from the VAERS database via a search of QScan on 24 February 2009. The FLUZONE was injected intramuscularly, and all events occurred on 08 October 2008. VAERS reference number was provided as 328067.
Age: 38.0
Sex: F
Vaccine: FLU3
Symptoms: Body temperature increased, Burning sensation, Cough, Dyspnoea, Headache
Clinical narrative: Burning sensation, Dyspnoea, neck pain, eyes red, coughing, general body pain, headache, temperature elevation. This case was received from the Centers for Disease Control and Prevention (CDC) in the United States on 03 November, 2008 under VAERS reference number 328284-1. A 38-year-old female patient with a history of mold, grass, pollen and dust allergies, had received an injection of FLUZONE SV  2008-2009, lot number US809AA on 07 August 2008 and at approximately 16:30 hours that day, she developed coughing, burning in her chest, and it became hard for her to breath. The patient had been outside taking her daughter to a dance. At approximately 19:00 hours, she developed body aches, neck ache and a headache. At 19:30 hours, her eyes became red and she had a temperature of 100.4; the patient took Ibuprofen. The patient slept and still had a slight neck ache and body aches. Her temperature had been 97.9 that morning and the patient took Ibuprofen again. According to the reporter, the patient recovered from the event. Follow-up information was extracted from the VAERS database via a search of QSCAN on 24 February 2009. The FLUZONE was given intramuscularly. No additional new information was provided.
Age: 38.0
Sex: F
Vaccine: FLU3
Symptoms: Neck pain, Ocular hyperaemia, Pain
Clinical narrative: Burning sensation, Dyspnoea, neck pain, eyes red, coughing, general body pain, headache, temperature elevation. This case was received from the Centers for Disease Control and Prevention (CDC) in the United States on 03 November, 2008 under VAERS reference number 328284-1. A 38-year-old female patient with a history of mold, grass, pollen and dust allergies, had received an injection of FLUZONE SV  2008-2009, lot number US809AA on 07 August 2008 and at approximately 16:30 hours that day, she developed coughing, burning in her chest, and it became hard for her to breath. The patient had been outside taking her daughter to a dance. At approximately 19:00 hours, she developed body aches, neck ache and a headache. At 19:30 hours, her eyes became red and she had a temperature of 100.4; the patient took Ibuprofen. The patient slept and still had a slight neck ache and body aches. Her temperature had been 97.9 that morning and the patient took Ibuprofen again. According to the reporter, the patient recovered from the event. Follow-up information was extracted from the VAERS database via a search of QSCAN on 24 February 2009. The FLUZONE was given intramuscularly. No additional new information was provided.
Age: 66.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Eye swelling, Headache, Injection site streaking, Ocular hyperaemia, Oedema peripheral
Clinical narrative: This case was received from a local health authority on 03 November 2008, under VAERS reference number 328352-1.  A 66-year-old female patient with a medical history of ostecarthritis knee pain, received an injection of FLUZONE SV 2008-2009, lot number U2745AA, and  an injection of PNEUMOVAX (manufactured by MERCK), lot number 0813X on 02 October 2008. The patient had been taking PREMARIN concomitantly. On the evening of vaccination, the patient experienced wheezing, throat tightening and red eyes. The following day, she developed a swollen pink eye and a headache. On the second day, the patient noticed some swelling of her arm and streaks along her shoulder and under her arm. The patient also reported having having a fever. Corrective treatments included BENADRYL, which the patient began taking "on the first day". At the time of the report, the patient was reported as recovered from the event. Follow-up information was extracted from VAERS via a search of QScan on 24 February 2009. FLUZONE and PNEUMOVAX were both administered intramuscularly. Reference number was provided as 328352.
Age: 66.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Pyrexia, Throat tightness, Wheezing
Clinical narrative: This case was received from a local health authority on 03 November 2008, under VAERS reference number 328352-1.  A 66-year-old female patient with a medical history of ostecarthritis knee pain, received an injection of FLUZONE SV 2008-2009, lot number U2745AA, and  an injection of PNEUMOVAX (manufactured by MERCK), lot number 0813X on 02 October 2008. The patient had been taking PREMARIN concomitantly. On the evening of vaccination, the patient experienced wheezing, throat tightening and red eyes. The following day, she developed a swollen pink eye and a headache. On the second day, the patient noticed some swelling of her arm and streaks along her shoulder and under her arm. The patient also reported having having a fever. Corrective treatments included BENADRYL, which the patient began taking "on the first day". At the time of the report, the patient was reported as recovered from the event. Follow-up information was extracted from VAERS via a search of QScan on 24 February 2009. FLUZONE and PNEUMOVAX were both administered intramuscularly. Reference number was provided as 328352.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Back pain, Chills, Eye irritation, Ocular hyperaemia, Oropharyngeal blistering
Clinical narrative: This case was received from the CDC (Centers for Disease Control and Prevention) on 03 November 2008, under VAERS reference number 328588-1. A 60-year-old female received an injection of FLUZONE SV 2008-2009 (lot number U2740AA) on 13 October 2008. On an unspecified date, the patient experienced back ache, burning and bloodshot eyes, swollen tongue, blisters in her mouth and chills. The patient recovered. No additional information was provided.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Swollen tongue
Clinical narrative: This case was received from the CDC (Centers for Disease Control and Prevention) on 03 November 2008, under VAERS reference number 328588-1. A 60-year-old female received an injection of FLUZONE SV 2008-2009 (lot number U2740AA) on 13 October 2008. On an unspecified date, the patient experienced back ache, burning and bloodshot eyes, swollen tongue, blisters in her mouth and chills. The patient recovered. No additional information was provided.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Dyspnoea, Eye discharge, Eye pruritus, Feeling cold, Headache
Clinical narrative: This case was extracted from the VAERS database via QScan on 24 February 2009 (reference number 328987). A 53-year-old female patient had received a fifth dose intramuscular injection of FLUZONE No preservative 2008-2009, lot number U2790BA (lot number reported as PMC-U2790BA) on 15 October 2008 and an unspecified amount of time following vaccination at approximately 17:30 hours, she developed "scratchy" eyes, blurry vision and felt like she could not take a deep breath. After a while (amount of time not specified) she felt like her throat was closing up and she developed mucus in her eyes. She waited for her husband to return home and he then took her to the emergency room at approximately 20:00 hours. The patient reported her breathing was better by that time, but she had a "horrible" headache and was "freezing". She was administered a breathing treatment, and subsequently discharged with an inhaler and Benadryl. The next morning, the symptoms of horrible headache, bloodshot eyes and chilling continued. At the time of the report, the patient continued to have "scratchy" eyes, but all other symptoms had subsided. Documents held by sender: None.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Pharyngeal oedema, Vision blurred
Clinical narrative: This case was extracted from the VAERS database via QScan on 24 February 2009 (reference number 328987). A 53-year-old female patient had received a fifth dose intramuscular injection of FLUZONE No preservative 2008-2009, lot number U2790BA (lot number reported as PMC-U2790BA) on 15 October 2008 and an unspecified amount of time following vaccination at approximately 17:30 hours, she developed "scratchy" eyes, blurry vision and felt like she could not take a deep breath. After a while (amount of time not specified) she felt like her throat was closing up and she developed mucus in her eyes. She waited for her husband to return home and he then took her to the emergency room at approximately 20:00 hours. The patient reported her breathing was better by that time, but she had a "horrible" headache and was "freezing". She was administered a breathing treatment, and subsequently discharged with an inhaler and Benadryl. The next morning, the symptoms of horrible headache, bloodshot eyes and chilling continued. At the time of the report, the patient continued to have "scratchy" eyes, but all other symptoms had subsided. Documents held by sender: None.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Feeling abnormal, Flushing, Injection site pain, Tension headache
Clinical narrative: This case was received on 03 November 2008, under VARES reference number 329035-1. A 39-year-old female had received an injection of FLUZONE SV (lot number reported as 89882, not a valid lot number) on 18 October 2008 at approximately 11:30 am at a local store. Following the vaccine, the patient felt normal tenderness in the location of the vaccine. The patient completed her errands and returned home at approximately 1:30 pm, at which time she noticed that her face was flushed and her eyes felt like it had expanded making her upper jaw feel very strange and enlarged. Her head overall felt like there was a vice gripe on it, described as a strange tightening feeling that extended down the back of her neck. The patient called her doctor's answering service and spoke to the doctor on call at approximately 2:45 pm. The doctor indicated it was probably not due to the vaccine and instructed the patient to take Ibuprofen and drink fluids. The patient was also told that if other symptoms developed, she should call the doctor back or go to the emergency room for evaluation. Patient outcome was not reported.
Age: 3.0
Sex: F
Vaccine: FLU3, HEPA, MMR, VARCEL
Symptoms: Conjunctivitis, Cough, Pyrexia, Rhinorrhoea, Upper respiratory tract infection
Clinical narrative: This case was received on 24 February 2009 via a search of the VAERS database (reference number 329177). A 3 year old female received FLUZONE No Preservative (lot number UT2475AA) intramuscularly, VARIVAX (manufacturer Merck, lot number 1510U) subcutaneously, HAVRIX (manufacturer GSK, lot number AHAUB2) intramuscularly, and MMR II (manufacturer Merck, lot number 1216F) subcutaneously on 26 February 2008. On 27 February 2008 the patient developed a fever of 105.2. The mother took the patient to the emergency room three days later with symptoms of a upper respiratory infection (URI) including cough, runny nose, and conjunctive excudate, rule out URI. (also reported as UTI). The patient was reported as recovered. No further information was provided. List of Documents held by Sender: none.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Blood test normal, Chest discomfort, Computerised tomogram normal, Cough, Dyspnoea
Clinical narrative: This case was received from the CDC (Centers for Disease Control and Prevention) on 03 November 2008, under VAERS reference number 329231. The case was assessed as non-serious by the CDC; however, it was upgraded to serious by the Company. A 57-year-old female patient, with no reported medical history, received an injection of FLUZONE SV 2008-2009 (lot number U2802AA) on 14 October 2008. Concomitant medications included PROZAC and BETAPACE. Approximately four hours after vaccination, the patient began complaining of coughing, chest tightening, difficulty breathing, and tightening pain in her jaws. Her eyes became bloodshot. She was transported to a hospital via ambulance, and underwent a CAT scan, doppler study, x-rays, kidney function test, chemical stress test, and other unknown blood tests. All test results were negative. Treatment included "nitro and steroids", and the patient was discharged home the same evening. According to the patient, the event was "an allergic reaction to something". The symptoms resolved the evening of vaccination, and the patient was considered to be recovered. Follow-up information received on 24 February 2009 via search of the VAERS database through QSCAN FDA report (Reference number 329231). The FLUZONE SV 2008-2009 was administered at 09:00 am on 14 October 2008. Documents held by sender: None.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Hypersensitivity, Laboratory test normal, Muscle tightness, Ocular hyperaemia, Pain in jaw
Clinical narrative: This case was received from the CDC (Centers for Disease Control and Prevention) on 03 November 2008, under VAERS reference number 329231. The case was assessed as non-serious by the CDC; however, it was upgraded to serious by the Company. A 57-year-old female patient, with no reported medical history, received an injection of FLUZONE SV 2008-2009 (lot number U2802AA) on 14 October 2008. Concomitant medications included PROZAC and BETAPACE. Approximately four hours after vaccination, the patient began complaining of coughing, chest tightening, difficulty breathing, and tightening pain in her jaws. Her eyes became bloodshot. She was transported to a hospital via ambulance, and underwent a CAT scan, doppler study, x-rays, kidney function test, chemical stress test, and other unknown blood tests. All test results were negative. Treatment included "nitro and steroids", and the patient was discharged home the same evening. According to the patient, the event was "an allergic reaction to something". The symptoms resolved the evening of vaccination, and the patient was considered to be recovered. Follow-up information received on 24 February 2009 via search of the VAERS database through QSCAN FDA report (Reference number 329231). The FLUZONE SV 2008-2009 was administered at 09:00 am on 14 October 2008. Documents held by sender: None.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Renal function test normal, Ultrasound Doppler normal, X-ray normal
Clinical narrative: This case was received from the CDC (Centers for Disease Control and Prevention) on 03 November 2008, under VAERS reference number 329231. The case was assessed as non-serious by the CDC; however, it was upgraded to serious by the Company. A 57-year-old female patient, with no reported medical history, received an injection of FLUZONE SV 2008-2009 (lot number U2802AA) on 14 October 2008. Concomitant medications included PROZAC and BETAPACE. Approximately four hours after vaccination, the patient began complaining of coughing, chest tightening, difficulty breathing, and tightening pain in her jaws. Her eyes became bloodshot. She was transported to a hospital via ambulance, and underwent a CAT scan, doppler study, x-rays, kidney function test, chemical stress test, and other unknown blood tests. All test results were negative. Treatment included "nitro and steroids", and the patient was discharged home the same evening. According to the patient, the event was "an allergic reaction to something". The symptoms resolved the evening of vaccination, and the patient was considered to be recovered. Follow-up information received on 24 February 2009 via search of the VAERS database through QSCAN FDA report (Reference number 329231). The FLUZONE SV 2008-2009 was administered at 09:00 am on 14 October 2008. Documents held by sender: None.
Age: 5.0
Sex: M
Vaccine: FLU3
Symptoms: Eye swelling, Oxygen supplementation, Swelling face, Tachycardia
Clinical narrative: Initial information was received on 03 November 2008 from the CDC (Center for Disease Control and Detection) under VAERS reference number 329798-1. A 5 year old male patient with a history of cerebral palsy, seizures, GERD (gastroesophageal reflux disease) and developmental delay received FLUZONE (lot number U2750AA) on 21 October 2008. At 2:40 pm the patient developed swelling of the eyes and across the nasal bridge. The ambulance was called at 2:45 pm. The patient received oxygen at 10 liters via 100% rebreather, pulse oximeter was 96%, pulse was 160-170 and blood pressure was 112/62. The patient was not in any respiratory distress, lungs and airway were both clear. The patient received BENADRYL 12.5 mg intramuscularly patient was given epinephrine 1:1000 0.3 ml. At 2:55 pm the patient was transported to the hospital via ambulance. List of Documents held by Sender: None.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site irritation, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Initial report was received 23 October 2008 from a health care professional in the United States who submitted the report to VAERS; temporary E-report number E-25742. A 39-year old female patient had received an intramuscular right arm injection of FLUZONE, lot number U2789BA on 20 October 2008, and she experienced an intense burning at the injection site at the time of vaccination. Four hours later, the patient developed a "right sided migraine type headache with a little blurred vision and color aura" (which was reported as being normal for the patient when a migraine occurred). Some slight injection swelling and irritation developed later that evening. The patient took Ibuprofen 600mg for headache "which was what she normally takes for headache" and applied ice to the injection site. Upon awakening 21 October 2008, the patient complained of injection site itching, redness, heat, and swelling. The patient took Ibuprofen 600mg at 06:00am and 12:00pm with no relief. The symptom of headache continued so the patient took two tablets of EXCEDRIN Migraine at 17:30pm and her arm symptoms continued with burning, itching, redness and localized pain. Her headaches resolved by the following morning on 22 October 2008 however her "arm symptoms continued". The patient was evaluated by a registered nurse on 23 October 2008 who noted a "2.5 x 4.5" area of induration, warmth and firmness. Skin color not changed". The patient was instructed to use ice or heat for comfort, OTC cream or lotion for the itching as needed, and to follow-up with their primary care physician if symptoms worsened. At the time of the report, the patient had not recovered from the event.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site warmth, Migraine, Skin discolouration, Vision blurred
Clinical narrative: Initial report was received 23 October 2008 from a health care professional in the United States who submitted the report to VAERS; temporary E-report number E-25742. A 39-year old female patient had received an intramuscular right arm injection of FLUZONE, lot number U2789BA on 20 October 2008, and she experienced an intense burning at the injection site at the time of vaccination. Four hours later, the patient developed a "right sided migraine type headache with a little blurred vision and color aura" (which was reported as being normal for the patient when a migraine occurred). Some slight injection swelling and irritation developed later that evening. The patient took Ibuprofen 600mg for headache "which was what she normally takes for headache" and applied ice to the injection site. Upon awakening 21 October 2008, the patient complained of injection site itching, redness, heat, and swelling. The patient took Ibuprofen 600mg at 06:00am and 12:00pm with no relief. The symptom of headache continued so the patient took two tablets of EXCEDRIN Migraine at 17:30pm and her arm symptoms continued with burning, itching, redness and localized pain. Her headaches resolved by the following morning on 22 October 2008 however her "arm symptoms continued". The patient was evaluated by a registered nurse on 23 October 2008 who noted a "2.5 x 4.5" area of induration, warmth and firmness. Skin color not changed". The patient was instructed to use ice or heat for comfort, OTC cream or lotion for the itching as needed, and to follow-up with their primary care physician if symptoms worsened. At the time of the report, the patient had not recovered from the event.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Blood pressure increased, Dysphonia, Dyspnoea, Heart rate increased, Ocular hyperaemia
Clinical narrative: This case was received on 24 February 2009 via a search of the VAERS database (reference number 330097).  A 50 year old female patient received FLUZONE SV 2008-2009 (lot number U2750AA) on 21 October 2008.  On the same day, post vaccination the patient developed difficulty breathing, hoarseness, wheezing, heightened blood pressure and pulse, bloodshot eyes.  Treatment included over the counter allergy pills.  The patient was reported as recovered.  No further information was provided.  List of Documents held by Sender:  none.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Wheezing
Clinical narrative: This case was received on 24 February 2009 via a search of the VAERS database (reference number 330097).  A 50 year old female patient received FLUZONE SV 2008-2009 (lot number U2750AA) on 21 October 2008.  On the same day, post vaccination the patient developed difficulty breathing, hoarseness, wheezing, heightened blood pressure and pulse, bloodshot eyes.  Treatment included over the counter allergy pills.  The patient was reported as recovered.  No further information was provided.  List of Documents held by Sender:  none.
Age: 69.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Chest X-ray, Convulsion, Dyspnoea, Full blood count, Laboratory test
Clinical narrative: This serious case was extracted from the VAERS database on 12 Feburary 2009 via a search of QScan (reference number 330623). A 69-year-old female patient with no reported medical history received an intramuscular injection of FLUZONE (lot number U2811) on 29 October 2008. On the day of vaccination, she experienced nausea, wheezing, shortness of breath, throat swelling, eye redness, and "small seizure" en route to the Hospital. She underwent a CBC, Chem 7, and chest X-ray: results were not reported. The patient was hospitalized, and the event required intervention to prevent permanent impairment/damage. The patient recovered. 24 February 2009; A new version was created with the same latest received date as the previous version (12 February 2009) as a result of internal review where it was identified that this case was duplicate of case 2008-03486. The information from this case (2009-00560) has been entered into case 2008-03486 and this case (2009-00560) will be nullified and subsequently logically deleted.
Age: 69.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Nausea, Ocular hyperaemia, Pharyngeal oedema, Wheezing
Clinical narrative: This serious case was extracted from the VAERS database on 12 Feburary 2009 via a search of QScan (reference number 330623). A 69-year-old female patient with no reported medical history received an intramuscular injection of FLUZONE (lot number U2811) on 29 October 2008. On the day of vaccination, she experienced nausea, wheezing, shortness of breath, throat swelling, eye redness, and "small seizure" en route to the Hospital. She underwent a CBC, Chem 7, and chest X-ray: results were not reported. The patient was hospitalized, and the event required intervention to prevent permanent impairment/damage. The patient recovered. 24 February 2009; A new version was created with the same latest received date as the previous version (12 February 2009) as a result of internal review where it was identified that this case was duplicate of case 2008-03486. The information from this case (2009-00560) has been entered into case 2008-03486 and this case (2009-00560) will be nullified and subsequently logically deleted.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Cough, Fluid replacement, Hypoaesthesia oral, Ocular hyperaemia
Clinical narrative: This case was received on 24 February 2009 via a search of the VAERS database (reference number 331010). A 46 year old female patient received FLUZONE SV 2008-2009 (U2770AA) intramuscularly on 15 October 2008. Approximately one to two hours later the patient developed a dry, hacky, persistent cough with chest tightness. The cough increased in intensity and frequency. She felt her throat closing and her tongue grew numb. Her lips began to tingle and her eyes turned bright red. As a result, she went to the emergency room. The patient's oxygen saturation was in the 80's. Treatment included nasal cannula, NaCl, SOLUMEDROL, PEPCID, BENADRYL intravenously. Shortly after receiving treatment, the patient felt her chest opening and had less throat irritation. The patient was placed on Prednisone 5 mg for three days. The patient was encouraged to see an allergist. The patient's outcome was reported as being hospitalized and recovered. The patient recovered ten days from the date of onset. List of Documents held by Sender: None.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Oxygen saturation decreased, Oxygen supplementation, Paraesthesia oral, Throat irritation, Throat tightness
Clinical narrative: This case was received on 24 February 2009 via a search of the VAERS database (reference number 331010). A 46 year old female patient received FLUZONE SV 2008-2009 (U2770AA) intramuscularly on 15 October 2008. Approximately one to two hours later the patient developed a dry, hacky, persistent cough with chest tightness. The cough increased in intensity and frequency. She felt her throat closing and her tongue grew numb. Her lips began to tingle and her eyes turned bright red. As a result, she went to the emergency room. The patient's oxygen saturation was in the 80's. Treatment included nasal cannula, NaCl, SOLUMEDROL, PEPCID, BENADRYL intravenously. Shortly after receiving treatment, the patient felt her chest opening and had less throat irritation. The patient was placed on Prednisone 5 mg for three days. The patient was encouraged to see an allergist. The patient's outcome was reported as being hospitalized and recovered. The patient recovered ten days from the date of onset. List of Documents held by Sender: None.
Age: 66.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Anaphylactic reaction, Chest discomfort, Conjunctivitis, Cough, Dyspnoea
Clinical narrative: This serious case was extracted from the VAERS database via QSCAN on 24 February 2009 (reference number 331043). A 66-year-old female patient with no past history of reactions to flu vaccines, had received an intramuscular injection of FLUZONE No Preservative, lot number U2793EA on 22 October 2008 and approximately two hours later, she experienced eye discomfort, eye swelling, heat, chest tightness, cough (onset also reported as three hours post vaccination) and jaw discomfort. Three hours after receiving the vaccine, the patient experienced dyspnea, conjunctivitis, rhinitis, and ST (not specified) so she returned to the doctor's office. While in the office, she became hypotensive; her blood pressure was 80/50. The patient was diagnosed with anaphylaxis and administered IM BENADRYL and Epinephrine. The patient was subsequently transported by ambulance to the emergency room. Emergency room medical records for dates of service 22 October 2008 revealed that the patient had been improving upon arrival. Examination findings noted dramatic swelling and crusting of the eyes, scleral injection and tongue cramping. Pulse ox was initially 91%, BP supine 130/76, and standing 106 systolic. The patient was administered intravenous TAGAMET and recovered. The final diagnosis had been acute allergic reaction and conjunctivitis and the event was considered to be life threatening.
Age: 66.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Eye swelling, Eyelid margin crusting, Feeling hot, Hypersensitivity, Hypotension
Clinical narrative: This serious case was extracted from the VAERS database via QSCAN on 24 February 2009 (reference number 331043). A 66-year-old female patient with no past history of reactions to flu vaccines, had received an intramuscular injection of FLUZONE No Preservative, lot number U2793EA on 22 October 2008 and approximately two hours later, she experienced eye discomfort, eye swelling, heat, chest tightness, cough (onset also reported as three hours post vaccination) and jaw discomfort. Three hours after receiving the vaccine, the patient experienced dyspnea, conjunctivitis, rhinitis, and ST (not specified) so she returned to the doctor's office. While in the office, she became hypotensive; her blood pressure was 80/50. The patient was diagnosed with anaphylaxis and administered IM BENADRYL and Epinephrine. The patient was subsequently transported by ambulance to the emergency room. Emergency room medical records for dates of service 22 October 2008 revealed that the patient had been improving upon arrival. Examination findings noted dramatic swelling and crusting of the eyes, scleral injection and tongue cramping. Pulse ox was initially 91%, BP supine 130/76, and standing 106 systolic. The patient was administered intravenous TAGAMET and recovered. The final diagnosis had been acute allergic reaction and conjunctivitis and the event was considered to be life threatening.
Age: 66.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Ocular hyperaemia, Oxygen saturation, Rhinitis, Scleral disorder, Tongue disorder
Clinical narrative: This serious case was extracted from the VAERS database via QSCAN on 24 February 2009 (reference number 331043). A 66-year-old female patient with no past history of reactions to flu vaccines, had received an intramuscular injection of FLUZONE No Preservative, lot number U2793EA on 22 October 2008 and approximately two hours later, she experienced eye discomfort, eye swelling, heat, chest tightness, cough (onset also reported as three hours post vaccination) and jaw discomfort. Three hours after receiving the vaccine, the patient experienced dyspnea, conjunctivitis, rhinitis, and ST (not specified) so she returned to the doctor's office. While in the office, she became hypotensive; her blood pressure was 80/50. The patient was diagnosed with anaphylaxis and administered IM BENADRYL and Epinephrine. The patient was subsequently transported by ambulance to the emergency room. Emergency room medical records for dates of service 22 October 2008 revealed that the patient had been improving upon arrival. Examination findings noted dramatic swelling and crusting of the eyes, scleral injection and tongue cramping. Pulse ox was initially 91%, BP supine 130/76, and standing 106 systolic. The patient was administered intravenous TAGAMET and recovered. The final diagnosis had been acute allergic reaction and conjunctivitis and the event was considered to be life threatening.
Age: 66.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Anaphylactic reaction, Chest discomfort, Conjunctival hyperaemia, Conjunctivitis, Cough
Clinical narrative: This serious case was extracted from the VAERS database via QSCAN on 24 February 2009 (reference number 331043). A 66-year-old female patient with no past history of reactions to flu vaccines, had received an intramuscular injection of FLUZONE No Preservative, lot number U2793EA on 22 October 2008 and approximately two hours later, she experienced eye discomfort, eye swelling, heat, chest tightness, cough (onset also reported as three hours post vaccination) and jaw discomfort. Three hours after receiving the vaccine, the patient experienced dyspnea, conjunctivitis, rhinitis, and ST (not specified) so she returned to the doctor's office. While in the office, she became hypotensive; her blood pressure was 80/50. The patient was diagnosed with anaphylaxis and administered IM BENADRYL and Epinephrine. The patient was subsequently transported by ambulance to the emergency room. Emergency room medical records for dates of service 22 October 2008 revealed that the patient had been improving upon arrival. Examination findings noted dramatic swelling and crusting of the eyes, scleral injection and tongue cramping. Pulse ox was initially 91%, BP supine 130/76, and standing 106 systolic. The patient was administered intravenous TAGAMET and recovered. The final diagnosis had been acute allergic reaction and conjunctivitis and the event was considered to be life threatening.
Age: 66.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Dyspnoea, Eye swelling, Feeling hot, Glossodynia, Hypersensitivity
Clinical narrative: This serious case was extracted from the VAERS database via QSCAN on 24 February 2009 (reference number 331043). A 66-year-old female patient with no past history of reactions to flu vaccines, had received an intramuscular injection of FLUZONE No Preservative, lot number U2793EA on 22 October 2008 and approximately two hours later, she experienced eye discomfort, eye swelling, heat, chest tightness, cough (onset also reported as three hours post vaccination) and jaw discomfort. Three hours after receiving the vaccine, the patient experienced dyspnea, conjunctivitis, rhinitis, and ST (not specified) so she returned to the doctor's office. While in the office, she became hypotensive; her blood pressure was 80/50. The patient was diagnosed with anaphylaxis and administered IM BENADRYL and Epinephrine. The patient was subsequently transported by ambulance to the emergency room. Emergency room medical records for dates of service 22 October 2008 revealed that the patient had been improving upon arrival. Examination findings noted dramatic swelling and crusting of the eyes, scleral injection and tongue cramping. Pulse ox was initially 91%, BP supine 130/76, and standing 106 systolic. The patient was administered intravenous TAGAMET and recovered. The final diagnosis had been acute allergic reaction and conjunctivitis and the event was considered to be life threatening.
Age: 66.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Hypotension, Jaw disorder, Ocular discomfort, Rhinitis, Scab
Clinical narrative: This serious case was extracted from the VAERS database via QSCAN on 24 February 2009 (reference number 331043). A 66-year-old female patient with no past history of reactions to flu vaccines, had received an intramuscular injection of FLUZONE No Preservative, lot number U2793EA on 22 October 2008 and approximately two hours later, she experienced eye discomfort, eye swelling, heat, chest tightness, cough (onset also reported as three hours post vaccination) and jaw discomfort. Three hours after receiving the vaccine, the patient experienced dyspnea, conjunctivitis, rhinitis, and ST (not specified) so she returned to the doctor's office. While in the office, she became hypotensive; her blood pressure was 80/50. The patient was diagnosed with anaphylaxis and administered IM BENADRYL and Epinephrine. The patient was subsequently transported by ambulance to the emergency room. Emergency room medical records for dates of service 22 October 2008 revealed that the patient had been improving upon arrival. Examination findings noted dramatic swelling and crusting of the eyes, scleral injection and tongue cramping. Pulse ox was initially 91%, BP supine 130/76, and standing 106 systolic. The patient was administered intravenous TAGAMET and recovered. The final diagnosis had been acute allergic reaction and conjunctivitis and the event was considered to be life threatening.
Age: 66.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Anaphylactic reaction, Chest discomfort, Conjunctivitis, Cough, Dyspnoea
Clinical narrative: This serious case was extracted from the VAERS database via QSCAN on 24 February 2009 (reference number 331043). A 66-year-old female patient with no past history of reactions to flu vaccines, ahd received an intramuscular injection of FLUZONE No Preservative 2008-2009, lot number U2793EA on 22 October 2008 and approximately two hours later, she experienced eye discomfort, eye swelling, heat, chest tightness, cough (onset also reported as three hours post vaccination) and jaw discomfort. Three hours after receiving the vaccine, the patient experienced dyspnea, conjunctivitis, rhinitis, and ST (not specified) so she returned to the doctor's office. While in the office, she became hypotensive; her blood pressure was 80/50. The patient was diagnosed with anaphylaxis and administered IM BENADRYL and EPINEPHRINE. The patient was subsequently transported by ambulance to the emergency room. Emergency room medical records for dates of service 22 October 2008 revealed that the patient had been improving upon arrival. Examination findings noted dramatic swelling and crusting of the eyes, scleral injection and tongue cramping. Pulse ox was initially 91%, BP supine 130/76, and standing 106 systolic. The patient was administered intravenous Tagamet and recovered. The final diagnosis had been acute allergic reaction and conjunctivitis and the event was considered to be life threatening.
Age: 66.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Eye swelling, Eyelid margin crusting, Feeling hot, Hypersensitivity, Hypotension
Clinical narrative: This serious case was extracted from the VAERS database via QSCAN on 24 February 2009 (reference number 331043). A 66-year-old female patient with no past history of reactions to flu vaccines, ahd received an intramuscular injection of FLUZONE No Preservative 2008-2009, lot number U2793EA on 22 October 2008 and approximately two hours later, she experienced eye discomfort, eye swelling, heat, chest tightness, cough (onset also reported as three hours post vaccination) and jaw discomfort. Three hours after receiving the vaccine, the patient experienced dyspnea, conjunctivitis, rhinitis, and ST (not specified) so she returned to the doctor's office. While in the office, she became hypotensive; her blood pressure was 80/50. The patient was diagnosed with anaphylaxis and administered IM BENADRYL and EPINEPHRINE. The patient was subsequently transported by ambulance to the emergency room. Emergency room medical records for dates of service 22 October 2008 revealed that the patient had been improving upon arrival. Examination findings noted dramatic swelling and crusting of the eyes, scleral injection and tongue cramping. Pulse ox was initially 91%, BP supine 130/76, and standing 106 systolic. The patient was administered intravenous Tagamet and recovered. The final diagnosis had been acute allergic reaction and conjunctivitis and the event was considered to be life threatening.
Age: 66.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Ocular hyperaemia, Oxygen saturation, Rhinitis, Scleral disorder, Tongue disorder
Clinical narrative: This serious case was extracted from the VAERS database via QSCAN on 24 February 2009 (reference number 331043). A 66-year-old female patient with no past history of reactions to flu vaccines, ahd received an intramuscular injection of FLUZONE No Preservative 2008-2009, lot number U2793EA on 22 October 2008 and approximately two hours later, she experienced eye discomfort, eye swelling, heat, chest tightness, cough (onset also reported as three hours post vaccination) and jaw discomfort. Three hours after receiving the vaccine, the patient experienced dyspnea, conjunctivitis, rhinitis, and ST (not specified) so she returned to the doctor's office. While in the office, she became hypotensive; her blood pressure was 80/50. The patient was diagnosed with anaphylaxis and administered IM BENADRYL and EPINEPHRINE. The patient was subsequently transported by ambulance to the emergency room. Emergency room medical records for dates of service 22 October 2008 revealed that the patient had been improving upon arrival. Examination findings noted dramatic swelling and crusting of the eyes, scleral injection and tongue cramping. Pulse ox was initially 91%, BP supine 130/76, and standing 106 systolic. The patient was administered intravenous Tagamet and recovered. The final diagnosis had been acute allergic reaction and conjunctivitis and the event was considered to be life threatening.
Age: 66.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Anaphylactic reaction, Chest discomfort, Conjunctival hyperaemia, Conjunctivitis, Cough
Clinical narrative: This serious case was extracted from the VAERS database via QSCAN on 24 February 2009 (reference number 331043). A 66-year-old female patient with no past history of reactions to flu vaccines, ahd received an intramuscular injection of FLUZONE No Preservative 2008-2009, lot number U2793EA on 22 October 2008 and approximately two hours later, she experienced eye discomfort, eye swelling, heat, chest tightness, cough (onset also reported as three hours post vaccination) and jaw discomfort. Three hours after receiving the vaccine, the patient experienced dyspnea, conjunctivitis, rhinitis, and ST (not specified) so she returned to the doctor's office. While in the office, she became hypotensive; her blood pressure was 80/50. The patient was diagnosed with anaphylaxis and administered IM BENADRYL and EPINEPHRINE. The patient was subsequently transported by ambulance to the emergency room. Emergency room medical records for dates of service 22 October 2008 revealed that the patient had been improving upon arrival. Examination findings noted dramatic swelling and crusting of the eyes, scleral injection and tongue cramping. Pulse ox was initially 91%, BP supine 130/76, and standing 106 systolic. The patient was administered intravenous Tagamet and recovered. The final diagnosis had been acute allergic reaction and conjunctivitis and the event was considered to be life threatening.
Age: 66.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Dyspnoea, Eye swelling, Feeling hot, Glossodynia, Hypersensitivity
Clinical narrative: This serious case was extracted from the VAERS database via QSCAN on 24 February 2009 (reference number 331043). A 66-year-old female patient with no past history of reactions to flu vaccines, ahd received an intramuscular injection of FLUZONE No Preservative 2008-2009, lot number U2793EA on 22 October 2008 and approximately two hours later, she experienced eye discomfort, eye swelling, heat, chest tightness, cough (onset also reported as three hours post vaccination) and jaw discomfort. Three hours after receiving the vaccine, the patient experienced dyspnea, conjunctivitis, rhinitis, and ST (not specified) so she returned to the doctor's office. While in the office, she became hypotensive; her blood pressure was 80/50. The patient was diagnosed with anaphylaxis and administered IM BENADRYL and EPINEPHRINE. The patient was subsequently transported by ambulance to the emergency room. Emergency room medical records for dates of service 22 October 2008 revealed that the patient had been improving upon arrival. Examination findings noted dramatic swelling and crusting of the eyes, scleral injection and tongue cramping. Pulse ox was initially 91%, BP supine 130/76, and standing 106 systolic. The patient was administered intravenous Tagamet and recovered. The final diagnosis had been acute allergic reaction and conjunctivitis and the event was considered to be life threatening.
Age: 66.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Hypotension, Jaw disorder, Ocular discomfort, Rhinitis, Scab
Clinical narrative: This serious case was extracted from the VAERS database via QSCAN on 24 February 2009 (reference number 331043). A 66-year-old female patient with no past history of reactions to flu vaccines, ahd received an intramuscular injection of FLUZONE No Preservative 2008-2009, lot number U2793EA on 22 October 2008 and approximately two hours later, she experienced eye discomfort, eye swelling, heat, chest tightness, cough (onset also reported as three hours post vaccination) and jaw discomfort. Three hours after receiving the vaccine, the patient experienced dyspnea, conjunctivitis, rhinitis, and ST (not specified) so she returned to the doctor's office. While in the office, she became hypotensive; her blood pressure was 80/50. The patient was diagnosed with anaphylaxis and administered IM BENADRYL and EPINEPHRINE. The patient was subsequently transported by ambulance to the emergency room. Emergency room medical records for dates of service 22 October 2008 revealed that the patient had been improving upon arrival. Examination findings noted dramatic swelling and crusting of the eyes, scleral injection and tongue cramping. Pulse ox was initially 91%, BP supine 130/76, and standing 106 systolic. The patient was administered intravenous Tagamet and recovered. The final diagnosis had been acute allergic reaction and conjunctivitis and the event was considered to be life threatening.
Age: 69.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Asthenia, Blood culture negative, Blood gases normal, Blood pressure increased
Clinical narrative: This serious case was extracted from the VAERS database via QSCAN on 12 February 2009 (reference number 331045). A 69-year-old female patient with no reported medical history received an intramuscular injection of FLUZONE (lot number U2831) on 15 October 2008. Prior to leaving the facility where she received the vaccination, she stated that her arm felt heavy. She then began to have worsening symptoms, including joint pains, cramping, headache, elevated blood pressure, fever (102 degrees Fahrenheit), skin red and burning, and eyes red and burning. She reported a "shocky" feeling. She presented to the emergency department, where she complained of band-like chest tightness, shaking, nausea, shortness of breath, dizziness, and a cough. She underwent a CT, ultrasound of the lungs and legs, chest x-ray, ABGs, and routine bloodwork, including blood cultures; no abnormalities were found. She was treated with ATIVAN, but continued to feel weak. She also received XANAX, after which she experienced diarrhea. The event was considered to be life-threatening, requiring intervention to prevent permanent impairment/damage. She subsequently recovered.